Minko T - Search Results

1

Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells.

Minko T, Batrakova EV, Li S, Li Y, Pakunlu RI, Alakhov VY, Kabanov AV. Minko T, et al. J Control Release. 2005 Jul 20;105(3):269-78. doi: 10.1016/j.jconrel.2005.03.019. J Control Release. 2005. PMID: 15939500 Free PMC article.

2

HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.

Minko T, Kopecková P, Pozharov V, Kopecek J. Minko T, et al. J Control Release. 1998 Jul 31;54(2):223-33. doi: 10.1016/s0168-3659(98)00009-1. J Control Release. 1998. PMID: 9724909

3

Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.

Minko T, Kopecková P, Kopecek J. Minko T, et al. J Control Release. 1999 May 20;59(2):133-48. doi: 10.1016/s0168-3659(98)00186-2. J Control Release. 1999. PMID: 10332049

4

Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.

Demoy M, Minko T, Kopecková P, Kopecek J. Demoy M, et al. Among authors: minko t. J Control Release. 2000 Oct 3;69(1):185-96. doi: 10.1016/s0168-3659(00)00301-1. J Control Release. 2000. PMID: 11018556

5

Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.

Minko T, Kopecková P, Kopecek J. Minko T, et al. J Control Release. 2001 Apr 28;71(3):227-37. doi: 10.1016/s0168-3659(01)00220-6. J Control Release. 2001. PMID: 11295216

6

Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.

Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, Stein S, Sinko PJ. Minko T, et al. Cancer Chemother Pharmacol. 2002 Aug;50(2):143-50. doi: 10.1007/s00280-002-0463-1. Epub 2002 Jun 11. Cancer Chemother Pharmacol. 2002. PMID: 12172980

7

Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.

Pakunlu RI, Cook TJ, Minko T. Pakunlu RI, et al. Among authors: minko t. Pharm Res. 2003 Mar;20(3):351-9. doi: 10.1023/a:1022687617318. Pharm Res. 2003. PMID: 12669953

8

Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.

Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. Dharap SS, et al. Among authors: minko t. J Control Release. 2003 Aug 28;91(1-2):61-73. doi: 10.1016/s0168-3659(03)00209-8. J Control Release. 2003. PMID: 12932638

9

Molecular targeting of drug delivery systems to cancer.

Minko T, Dharap SS, Pakunlu RI, Wang Y. Minko T, et al. Curr Drug Targets. 2004 May;5(4):389-406. doi: 10.2174/1389450043345443. Curr Drug Targets. 2004. PMID: 15134222 Review.

10

Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system.

Pakunlu RI, Wang Y, Tsao W, Pozharov V, Cook TJ, Minko T. Pakunlu RI, et al. Among authors: minko t. Cancer Res. 2004 Sep 1;64(17):6214-24. doi: 10.1158/0008-5472.CAN-04-0001. Cancer Res. 2004. PMID: 15342407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters